Natural product Anti-telomerase cancer therapy: Moringa oleifera (MO) extract suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and inhibits cancer progression via down-regulation of its target gene, 22/October/2016, 7.05 am

MiRNA therapy for Myocardial dysfunction: MiR-765 increases CDK inhibitor p27 expression, inhibits mTOR pathway, promotes autophagy in myocardial cells and prevents myocardial dysfunction via down-regulation of its target gene, 22/October/2016, 6.51 am
October 22, 2016
Natural product-based therapy for Idiopathic pulmonary fibrosis: Hibiscus syriacus (Rose of Sharon) extract increases TRF1 expression and ameliorates pulmonary fibrosis via upregulation of its target gene, 22/October/2015, 7.26 am
October 22, 2016
Show all

The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; and I.F: >42) stating that “The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.”  This study provides mechanistic insights into how TPP1 regulates telomerase function.

In connection with this finding, Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports that: Natural product Anti-telomerase cancer therapy: Moringa oleifera (MO) extract suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and inhibits cancer progression via down-regulation of its target gene


Significance:

Given that cancer causes the highest economic loss compared to all the known causes of death worldwide, there is an urgent need to find: (i) a cheaper alternative to the existing expensive drugs; (ii) a side-effect-free natural product-based drug; (iii) a way to effectively treat cancers that are resistant to anti-cancer drugs; and (iv) a way to effectively treat and eradicate metastatic progression of cancer.


Figure 1 Moringa Olifera tree. Moringa Olifera extract inhibits human cancer cell proliferation via down-regulation of Tripeptidyl Peptidase 1 (TPP1) and telomerase

Figure 1 Moringa Olifera tree. Moringa Olifera extract inhibits human cancer cell proliferation via down-regulation of Tripeptidyl Peptidase 1 (TPP1) and telomerase

Research Findings:

Idea Proposed/Formulated by:

Dr L Boominathan Ph.D.

Moringa oleifera (MO) extract, by increasing the expression of its target gene, it may suppress the expression of Tripeptidyl Peptidase 1 (TPP1). Remarkably, over 90% human tumors over express telomerase, suggesting that inhibition of its activity may increase the efficacy of anticancer therapy.  Thus, this study suggests that pharmacological formulations encompassing Moringa oleifera (MO) extract or an active compound isolated from it may be used to treat human cancers.


CitationBoominathan, L., Natural product Anti-telomerase cancer therapy: Moringa oleifera (MO) extract suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and inhibits cancer progression via down-regulation of its target gene, 22/October/2016, 7.04 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $100#

Undisclosed information: How Moringa oleifera (MO) suppresses the expression of Tripeptidyl Peptidase 1 (TPP1)

Satisfaction-guaranteed-if-not-refunded

Courtesy: When you cite drop us a line at info@genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com

# Research cooperation

Comments are closed.